Principal Executive Office

de-SPAC - Now known as Hadron Energy

Haymaker Acquisition Corp 4

SPAC; those two dates for the meeting; DLA Piper LLP seems like the main counsel to work on the document. Most meeting were at their office and they met with other counsel to discuss matters from the Def Proxy

Duane Morris LLP

Disclosed outside counsel shown in the ARTICLES OF INCORPORATION portion of the Def Proxy

Curaleaf Holdings, Inc.

Canadian issuer: management information circular dated 05/07/2026 furnished on Form 6-K filed 05/18/2026 (record date 05/05/2026); results 6-K 06/22/2026 reports arrangement approved by 99.93% of votes cast (no raw tallies on EDGAR)

Extended meeting to 3/2/2026

Resolute Holdings Management, Inc.

Pass via written consent

Paul, Weiss, Rifkind, Wharton & Garrison LLP

Action via written consent

Forward Industries, INC

EQV Ventures Acquisition

Keel Infrastructure Corp.

British Virgin Islands

eXp World Holdings

Gibson, Dunn, and Crutcher

Now AGNT. Might be completed but no proxy.

Sidley Austin LLP

Texas Capital Bancshares

ExxonMobil Corp.

Gibson, Dunn & Crutcher LLP

Pass via written consent

Cozen O’Connor LLP

Action via written Filed a PRE 14C

Liberty Media Corporation

Skadden, Arps, Slate, Meagher & Flom LLP (tax)

FWONA, FWONB, FWONK

The LGL Group, Inc.

TTEC Holdings, Inc.

Weatherford International plc

Initial vote failed and the company immediately proposed a move to Delaware as an alternative. That attempt is separately tracked

Dream Finders Homes

Foley & Lardner LLP

No vote report yet

Voyager Technologies

Latham & Watkins LLP

FirstCash Holdings, Inc.

Natural Gas Services Group, INC

Archer Aviation Inc.

Sonoma Pharmaceuticals, inc

Adjourned meeting to seek more votes.

Pass via written consent

Wilson Sonsini Goodrich & Rosati P.C. (“Wilson Sonsini”

Wave Life Science LTD

Dell Technologies

Skadden, Arps, Slate, Meagher & Flom LLP

Spruce Power Holding Corp

Jushi Holdings Inc.

Aptorum Group Ltd

Aptorum and DiamiR Biosciences merged

Pass via written consent

Thunder Power Holdings

Pass via written consent

Carter Ledyard & Milburn LLP

DeFi Development Corp.

Pass via written consent

Granite Ridge Resources

Weatherford International plc

This is the separately tracked second attempt to exit Ireland-- this time to Delaware; Approved needs to be sanctioned by High Court of Ireland.

Trulieve Cannabis Corp.

Haven't found vote totals just statements that it was approved

Nu-Med Plus, Inc.

No, but CEO Fred Tejada controls ~44.5% of voting power via Series X super-voting preferred and voting agreements

Share exchange; no proxy or information statement on EDGAR as of 10/27/2026 - 8-Ks (06/30 and 07/10/2026) require a proxy statement and stockholder meeting within 50 days of SEC clearance covering Utah-to-Nevada redomicile, 1-for-27 reverse split, authorized share increase to 500M, and name change; no meeting date set. Prelim. Proxy on Nov. 2, 2026

Energy Transfer LP

Redomiciliation was approved by the board of directors of the general partner in reliance in part on the recommendation of a Special Committee. Accomplished by filing a Certificate of Conversion.

Redomiciliation was approved by the board of directors of the general partner in reliance in part on the recommendation of a Special Committee. Accomplished by filing a Certificate of Conversion.

Redomiciliation was approved by the board of directors of the general partner in reliance in part on the recommendation of a Special Committee. Accomplished by filing a Certificate of Conversion.

USA Compression Partners

Redomiciliation was approved by the board of directors of the general partner in reliance in part on the recommendation of a Special Committee. Accomplished by filing a Certificate of Conversion.

Etoiles Capital Group Co. LTD

Yes - Etoiles Zeneo Investment / CEO Kit Shing Cheung 68.08% (13D 08/31/2026)

Loeb & Loeb LLP (S-4 copy-to counsel); David Fong & Co. (Hong Kong counsel)

Foreign private issuer: S-4 / 424B3 proxy statement-prospectus 09/21/2026 (no DEF 14A); AGM 10/15/2026, record date 09/17/2026 (15,110,000 Class A shares); results in 6-K 10/15/2026; domestication effective 10/19/2026 per 8-K12B; Nasdaq trading suspended since 10/2025 so market cap figure is stale

Sui Group Holdings

TopPoint Holdings

Pass via written consent

Outdoor Holding Company

In process of moving headquarters to Texas

No (ADAR1 15.8% largest holder)

Sidley Austin, Gibson Dunn

NextCure and Avere Therapeutics, both Delaware entities, propose to merge and as part of that plan to convert to a Texas entity. Re-domiciliation is Proposal 5 in the S-4 merger proxy (S-4 filed 08/18/2026; S-4/A 09/30/2026; not yet effective); special meeting and record date not set; vote standard majority of outstanding; renamed Avere Therapeutics; DGCL 205 petition hearing 11/06/2026 could delay the deal

LandBridge Co LLC (LB)

Pass via written consent

Vinson & Elkins Counsel and Baker Botts as counsel to special committee

Statement that it was approved by written consent without clear dates

Catheter Precision

Now known as Flyte Aviation

Pass via written consent

Pass via written consent

Special meeting (virtual); record date 10/01/2026; 30,751,822 shares; reincorporation via merger into newly formed BCB Delaware; vote standard majority of votes entitled to be cast; no franchise tax figure (proxy says Delaware franchise taxes may be greater than NJ); Laurel Hill proxy solicitor

Natural Grocers by Vitamin Cottage, Inc.

Pass via written consent

Yes - Isely Family Group ~57.3%

Debevoise & Plimpton LLP

DEF 14C filed and mailed 10/20/2026 (PRE 14C 09/15/2026); approved by written consent of Isely Family Group (13,215,255 shares, ~57.3% of voting power) as of record date 09/09/2026; conversion effective no earlier than 20 days after mailing; ~$66,400 Delaware franchise tax FY ended 9/30/2025; Texas charter includes 3% ownership threshold for derivative suits

No (Scott Farmer 14.0%)

Annual meeting 10/27/2026 (virtual); record date 08/31/2026; 400,701,115 shares; conversion under DGCL ch. 265 / WBCA 23B.09; vote standard majority of outstanding; no franchise tax figure or outside counsel disclosed; no 8-K results on EDGAR as of 10/27/2026

Texas Pacific Land Corporation

No (Horizon Kinetics ~14.5%)

Annual meeting 11/05/2026 (Dallas); record date 09/10/2026; 68,974,683 shares; Proposal 4 conversion requires majority of outstanding; ~$200K Delaware franchise tax FY2025; counsel not named; Innisfree proxy solicitor

Onfolio Holdings, Inc.

No (ATW Digital Assets XI 9.99%)

Redomestication proposal appeared in PRE 14A (09/22/2026) but was dropped from the DEF 14A dated 10/19/2026 for the 11/05/2026 special meeting (reverse split up to 1-for-250 and adjournment only); no explanation given; record date 09/23/2026; 2,499,248 shares; PRE 14A cited ~$200K/yr Delaware franchise tax; bylaws amended 09/29/2026 to lower quorum to one-third

Solidion Technology

No (Global Graphene Group ~20.3%)

DEF 14A dated 10/07/2026; annual meeting 11/18/2026 (virtual); record date 09/28/2026; 8,981,893 shares; Proposal 4 conversion requires two-thirds of outstanding shares (abstentions and broker non-votes count against); paid $78K Delaware franchise tax for most recent period and anticipates ~$200K next period; counsel not named

InMed Pharmaceuticals

No (ADAR1 Capital ~17.2%)

Norton Rose Fulbright US LLP; Gibson, Dunn & Crutcher LLP (S-4 cover; party allocation not stated)

Move via merger with Mentari Therapeutics: S-4 proxy statement/prospectus and management information circular, 424B3 dated 10/01/2026 (first mailed ~10/13/2026); annual general and special meeting 11/04/2026; redomestication (Proposal 3) requires two-thirds of votes cast; BCBCA dissent rights apply; company to be renamed Mentari Therapeutics; legacy InMed holders ~1% post-closing

Korsana Biosciences, Inc

No (FMR 6.9% largest holder)

DEF 14A 10/15/2026; special meeting 11/13/2026 (virtual); record date 10/07/2026; 45,541,358 shares; domestication under MBCA 9.20 requires two-thirds of shares entitled to vote; second attempt - at the 08/26/2026 annual meeting ~61.8% of votes cast (~44.8% of outstanding) fell short; Innisfree proxy solicitor; counsel not named

Melar Acquisition Corp.

Yes - Sponsor 58.9% pre-redemption

de-SPAC with Everli Global (combined company Everli Global Holdings, ticker EVRL); DEFM14A filed 10/05/2026 (dated 10/02/2026); EGM 10/22/2026, record date 09/28/2026; domestication proposal voted only by the Class B shareholder (1 share); business combination proposal 9,425,113 for / 23,978 against; 3,852,564 Class A shares redeemed (~$0.8M left in trust); meeting held at offices of Ellenoff Grossman & Schole LLP

PRE 14A filed 10/19/2026; annual meeting (virtual); record date 11/3/2026; 34,439,562 shares outstanding; proxy cites ~$50K FY2025 Delaware franchise tax + annual report fee and est. $74,350 total annual savings; cites NRS 78.207 reverse-split flexibility and officer exculpation; largest holders Victor Huang 22.4%, Derek Xu 18.5%

Vivos Therapeutics, Inc.,

PRE 14A filed 10/19/2026 (dated 10/13/2026); annual meeting (virtual); record date 10/9/2026; 33,609,393 shares outstanding (market cap approx. shares x ~$0.13 price); also proposes 1-for-20 to 1-for-40 reverse split for Nasdaq bid-price compliance; Series A and Series B preferred holders already gave written consent to reincorporation; no franchise tax dollar figure disclosed

PRE 14A filed 10/23/2026; annual meeting (in person, Denver); record date 10/30/2026; expects ~$125K Delaware franchise tax for 2026; est. $125K-$200K annual savings vs. ~$900 in Nevada fees

Atlas Energy Solutions

Vinson & Elkins LLP (counsel to Evaluation Committee); Richards, Layton & Finger, P.A. (Delaware counsel to Evaluation Committee)

PRE 14A filed 10/26/2026; special meeting, date and record date not yet set; Board approved by unanimous written consent 10/23/2026; Evaluation Committee process; $250K Delaware franchise tax in FY2025; Okapi Partners proxy solicitor; listed on NYSE and NYSE Texas; vote standard majority of outstanding shares

Willis Lease Finance Corp.

Proxy refers to a controlling stockholder (Willis family); percentage not in reviewed portion

Milbank LLP; Young Conaway Stargatt & Taylor, LLP (Delaware counsel); Brownstein Hyatt Farber Schreck, LLP (Nevada counsel); Norton Rose Fulbright US LLP (Texas counsel)

PRE 14A filed 10/26/2026; special meeting (virtual); record date 11/2/2026; special committee of independent, disinterested directors formed 4/29/2026; paid ~$255,490 Delaware franchise tax for 2025, est. ~$254K annual savings vs. $1,725 Nevada fees; vote standard majority of outstanding shares; Mediant proxy solicitor

Pass via written consent

Announced with 8-K alongside earnings.

Pass via written consent

Announced with 8-K alongside earnings.